drugset / Trial / NCT01769183
Squalamine for the Treatment in Proliferative Diabetic Retinopathy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the efficacy in the use of topical Squalamine Lactate Ophthalmic Solution, 0.2% in the treatment of retinal neovascularization resulting from proliferative diabetic retinopathy.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Squalamine | Unknown | 0.2 % | Topical |